Solid Biosciences (SLDB) Depreciation & Amortization (CF) (2017 - 2026)
Quarterly results put Depreciation & Amortization (CF) at $395000.0 for Q1 2026, down 2.95% from a year ago — trailing twelve months through Mar 2026 was $1.6 million (down 35.94% YoY), and the annual figure for FY2025 was $1.6 million, down 33.36%.
Solid Biosciences has reported Depreciation & Amortization (CF) over the past 10 years, most recently at $395000.0 for Q1 2026.
- Depreciation & Amortization (CF) reached $395000.0 in Q1 2026 per SLDB's latest filing, down from $467000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1.2 million in Q2 2024 and bottomed at $327000.0 in Q1 2024.
- Median Depreciation & Amortization (CF) over the past 5 years was $488000.0 (2024), compared with a mean of $557352.9.
- The largest annual shift saw Depreciation & Amortization (CF) skyrocketed 75.68% in 2024 before it tumbled 68.74% in 2025.
- Over 5 years, Depreciation & Amortization (CF) stood at $539000.0 in 2022, then increased by 8.91% to $587000.0 in 2023, then dropped by 16.87% to $488000.0 in 2024, then fell by 4.3% to $467000.0 in 2025, then fell by 15.42% to $395000.0 in 2026.
- Business Quant data shows Depreciation & Amortization (CF) for SLDB at $395000.0 in Q1 2026, $467000.0 in Q4 2025, and $376000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 123.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | 395,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 395,000.00 |
| Mar 31, 2026 | 395,000.00 |
| Dec 31, 2025 | 467,000.00 |
| Dec 31, 2025 | 467,000.00 |
| Sep 30, 2025 | 376,000.00 |
| Sep 30, 2025 | 376,000.00 |
| Jun 30, 2025 | 386,000.00 |
| Jun 30, 2025 | 386,000.00 |
| Mar 31, 2025 | 407,000.00 |
| Mar 31, 2025 | 407,000.00 |
| Dec 31, 2024 | 488,000.00 |
| Dec 31, 2024 | 488,000.00 |
| Sep 30, 2024 | 405,000.00 |
| Sep 30, 2024 | 405,000.00 |
| Jun 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.24 Mn |
| Mar 31, 2024 | 327,000.00 |
| Mar 31, 2024 | 327,000.00 |
| Dec 31, 2023 | 587,000.00 |
| Dec 31, 2023 | 587,000.00 |
| Sep 30, 2023 | 588,000.00 |
| Sep 30, 2023 | 588,000.00 |
| Jun 30, 2023 | 703,000.00 |
| Jun 30, 2023 | 703,000.00 |
| Mar 31, 2023 | 703,000.00 |
| Mar 31, 2023 | 703,000.00 |
| Dec 31, 2022 | 539,000.00 |
| Dec 31, 2022 | 539,000.00 |
| Sep 30, 2022 | 438,000.00 |
| Sep 30, 2022 | 438,000.00 |
| Jun 30, 2022 | 722,000.00 |
| Jun 30, 2022 | 722,000.00 |
| Mar 31, 2022 | 709,000.00 |
| Mar 31, 2022 | 709,000.00 |
| Dec 31, 2021 | 760,000.00 |
| Dec 31, 2021 | 760,000.00 |
| Sep 30, 2021 | 752,000.00 |
| Sep 30, 2021 | 752,000.00 |
| Jun 30, 2021 | 718,000.00 |
| Jun 30, 2021 | 718,000.00 |
| Mar 31, 2021 | 734,000.00 |
| Mar 31, 2021 | 734,000.00 |
| Dec 31, 2020 | 796,000.00 |
| Dec 31, 2020 | 796,000.00 |
| Sep 30, 2020 | 766,000.00 |
| Sep 30, 2020 | 766,000.00 |
| Jun 30, 2020 | 1.33 Mn |
| Jun 30, 2020 | 1.33 Mn |
| Mar 31, 2020 | 1.03 Mn |
| Mar 31, 2020 | 1.03 Mn |
| Dec 31, 2019 | 806,000.00 |
| Dec 31, 2019 | 806,000.00 |
| Sep 30, 2019 | 764,000.00 |
| Sep 30, 2019 | 764,000.00 |
| Jun 30, 2019 | 658,000.00 |
| Jun 30, 2019 | 658,000.00 |
| Mar 31, 2019 | 596,000.00 |
| Mar 31, 2019 | 596,000.00 |
| Dec 31, 2018 | 481,000.00 |
| Dec 31, 2018 | 481,000.00 |
| Sep 30, 2018 | 545,000.00 |
| Sep 30, 2018 | 545,000.00 |
| Jun 30, 2018 | 313,000.00 |
| Jun 30, 2018 | 313,000.00 |
| Mar 31, 2018 | 227,000.00 |
| Mar 31, 2018 | 227,000.00 |
| Dec 31, 2017 | 223,000.00 |
| Dec 31, 2017 | 223,000.00 |
| Sep 30, 2017 | 110,000.00 |
| Sep 30, 2017 | 110,000.00 |
| Jun 30, 2017 | 64,000.00 |
| Jun 30, 2017 | 64,000.00 |
| Mar 31, 2017 | 51,000.00 |
| Mar 31, 2017 | 51,000.00 |